Camlin Fine Sciences Limited has filed its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26. The filing, submitted to the stock exchanges, details the company's performance on environmental, social, and governance parameters. The report highlights the company's progress toward its 2030 sustainability targets, including energy management and water conservation milestones.

The company achieved a key regulatory milestone during the year by securing Zero Liquid Discharge (ZLD) consent for its Tarapur facility from the State Pollution Control Board. This reinforces its commitment to responsible water management. At the Dahej facility, desalinated water contributed approximately 79% to total water consumption, reducing dependence on freshwater sources. The company contributed ₹12 crore towards the desalination plant.

Sustainability Initiatives

Camlin Fine Sciences continued its decarbonization efforts by integrating a co-generation system with a briquette-fired boiler at the Tarapur facility. This resulted in power generation of approximately 100 MW per month. The company is also implementing transition projects for renewable energy, including hybrid wind and solar power at Dahej and solar power for Tarapur facilities, targeting about 35% of operating power.

The report disclosed that 73.16% of the capital expenditure (capex) in FY 2025-26 was directed towards technologies to improve environmental and social impacts. Additionally, five Product Carbon Footprint assessments were conducted during the year. The company worked on a GRI-aligned Sustainability Report for FY 2024-25 as a baseline year.

Operational and Financial Metrics

The company reported an export contribution of 68.81% to its total turnover. It serves 26 states nationally and 51 countries internationally. The manufacturing units are located in Tarapur and Dahej, with offices in Mumbai, Thane, and Tarapur.

The following table summarizes the employee and worker statistics as of the end of the financial year:

Governance and Compliance

The Board of Directors comprises 12 members, with female representation at 16.67%. The company reported no fines or penalties for non-compliance with regulations during FY 2025-26. However, it disclosed two environmental incidents: a material overflow at the Tarapur unit in May 2025 and a solvent line leakage fire at the Dahej unit in February 2026. Both incidents were contained, and corrective actions were implemented following regulatory directions.

The company confirmed that Corporate Social Responsibility (CSR) provisions are not applicable to it for the year. It maintains policies covering anti-corruption, anti-bribery, and equal opportunity, all available on its website. The Managing Director, Mr. Nirmal Momaya, is responsible for decision-making on sustainability-related issues under the guidance of the Board.

Camlin Fine Sciences Limited has secured 95.41% of the share capital in Vinpai following the conclusion of a simplified cash tender offer. The company now holds 4,351,894 shares and 4,325,158 theoretical voting rights in the French entity. Despite reaching this majority stake, Camlin Fine Sciences confirmed it will not request the Autorité des marchés financiers (AMF) to implement a squeeze-out procedure for Vinpai shares from the Euronext Growth Paris market.

The simplified cash tender offer, known as the offre publique d’achat simplifiée (OPAS), closed on July 6, 2026. The results of the offer were published by the AMF. The transaction targeted the remaining shares of Vinpai that were not already held by Camlin Fine Sciences.

Post-Offer Ownership Structure

The acquisition significantly increased Camlin Fine Sciences' control over Vinpai. The final ownership figures include 26,736 treasury shares treated as held by Camlin Fine Sciences in accordance with article L. 233-9, I, 2° of the French commercial code.

The calculation of theoretical voting rights is based on a total of 4,728,855 rights, in accordance with article 223-11, al 2 of the general regulation of the AMF.

Strategic Decision on Delisting

Camlin Fine Sciences referenced a previous press release dated March 16, 2026, regarding its decision not to pursue a squeeze-out. This means minority shareholders will retain their listing on the Euronext Growth Paris market, and the company will not force the buyout of remaining shares.

Advisors for the transaction included ALLinvest Securities as the presenting institution and FONTAINE AVOCATS as the legal advisor.